Showing results (221-230 of 446) with videos related to

Sort By:
Pageof 45
Pain Medicine (Malden, Mass.)|February 17, 2017
Problematic Use of Prescription Opioids and Medicinal Cannabis Among Patients Suffering from Chronic PainDaniel Feingold, Itay Goor-Aryeh, Silviu Bril, et al.
The American Journal on Addictions|March 27, 2015
Schizophrenia and hallucinogen persisting perception disorder: A clinical investigationShaul Lev-Ran, Daniel Feingold, Dmitri Rudinski, et al.
Schizophrenia Research|May 21, 2013
Differences in associations between cannabis and stimulant disorders in first admission psychosisGrant Sara, Philip Burgess, Gin S Malhi, et al.
Addiction (Abingdon, England)|March 18, 2025
Early identification of the use of potent benzylbenzimidazoles (nitazenes) through wastewater analysis: Two years of data from 22 countriesRichard Bade, Dhayaalini Nadarajan, Wayne Hall, et al.
Journal of Medical Internet Research|January 15, 2016
Establishing and Governing e-Mental Health Care in Australia: A Systematic Review of Challenges and A Call For Policy-Focussed ResearchCarla Meurk, Janni Leung, Wayne Hall, et al.
Harefuah|July 25, 2019
[MEDICAL MARIJUANA DEPENDENCE AMONG CHRONIC PAIN PATIENTS SUFFERING FROM DEPRESSION AND ANXIETY]Daniel Feingold, Silviu Brill, Itay Goor-Aryeh, et al.
Journal of Affective Disorders|April 29, 2017
Depression and anxiety among chronic pain patients receiving prescription opioids and medical marijuanaDaniel Feingold, Silviu Brill, Itay Goor-Aryeh, et al.
General Hospital Psychiatry|August 16, 2017
Misuse of prescription opioids among chronic pain patients suffering from anxiety: A cross-sectional analysisDaniel Feingold, Silviu Brill, Itay Goor-Aryeh, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 5, 2024
Predictors of changes in marijuana consumption in Germany during the covid-19 pandemicSally Olderbak, Justin Möckl, Christian Rauschert, et al.
Pageof 45